Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/10/2012CN1829482B Medicine box for treatment of dependence withdrawal
10/10/2012CN1822817B Inhalable formulations for treating pulmonary hypertension and methods of using same
10/10/2012CN1662251B Adjuvant enhanced immunotherapy
10/10/2012CN102725303A 4 ' - azido - nucleosides as anti - HCV compunds
10/10/2012CN102725302A 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
10/10/2012CN102725298A Hydroxy-substituted cold(III) porphyrin complexes as histone deacetylase inhibitors
10/10/2012CN102725297A Process for preparation of cephalosporin derivative
10/10/2012CN102725294A Crystalline forms of (s)-1-(4-(5-cyclopropyl-1h-pyrazol-3- ylamino)pyrrolo [1,2-f] [1,2,4] triazin-2-yl)-n-(6-fluoropyridin- 3-yl)-2-methylpyrrolidine-2-carboxamide
10/10/2012CN102725293A A polymorph form of nevirapine and its preparation
10/10/2012CN102725292A Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
10/10/2012CN102725291A Bicyclic pyridines and analogs as sirtuin modulators
10/10/2012CN102725290A Fused heterocyclic compounds as ion channel modulators
10/10/2012CN102725288A Method for manufacturing a 6-substituted-1-methyl-1H-benzimidazole derivative, and manufacturing intermediate from said method
10/10/2012CN102725287A 1,3,4-oxadiazole-2-carboxamide compound
10/10/2012CN102725285A (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerati
10/10/2012CN102725284A Compound suitable for the treatment of synucleopathies
10/10/2012CN102725283A Compounds and compositions as protein kinase inhibitors
10/10/2012CN102725281A Azole derivatives as WTN pathway inhibitors
10/10/2012CN102725274A Antimicrobial compounds and methods of making and using the same
10/10/2012CN102725264A Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
10/10/2012CN102725263A Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
10/10/2012CN102725261A Arachidonic acid analogs and methods for analgesic treatment using same
10/10/2012CN102725024A Enhanced anti-microbial PDT
10/10/2012CN102725003A Aldehydes for in vivo imaging of aldh in cancer stem cells
10/10/2012CN102724985A Use of lipid conjugates in the treatment of diseases associated with vasculature
10/10/2012CN102724984A Enterococcal cell wall components and antibacterial use thereof
10/10/2012CN102724983A Use of aerosolized levofloxacin for treating cystic fibrosis
10/10/2012CN102724982A Pemirolast for the treatment of systemic low grade inflammation
10/10/2012CN102724981A Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient
10/10/2012CN102724980A Therapeutic use of protein-polymer conjugates
10/10/2012CN102724979A Combination
10/10/2012CN102724978A Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases
10/10/2012CN102724977A Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
10/10/2012CN102724976A Metabolic imprinting effects of structured lipids
10/10/2012CN102724975A IRE-1 a inhibitors
10/10/2012CN102724974A Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
10/10/2012CN102724973A Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
10/10/2012CN102724972A Coated capsules and tablets of a fatty acid oil mixture
10/10/2012CN102724971A Improved pharmacokinetics of S-adenosylmethionine formulations
10/10/2012CN102724970A Tablet formulations of neratinib maleate
10/10/2012CN102724965A Carboxyvinyl polymer-containing nanoparticle suspensions
10/10/2012CN102724962A Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
10/10/2012CN102724961A Topical foam composition
10/10/2012CN102724960A Topical foam composition
10/10/2012CN102724884A Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
10/10/2012CN102724880A Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
10/10/2012CN102724878A Methods of providing weight loss therapy in patients with major depression
10/10/2012CN102724877A Fatty acid niacin conjugates and their uses
10/10/2012CN102724875A Pyrido[3,4-b]indoles and methods of use
10/10/2012CN102721756A Synthesis of (R)-N-methylnaltrexone
10/10/2012CN102719521A Application of cystine/glutamic acid reverse transporter xCT inhibitor in treating liver cancer
10/10/2012CN102719397A Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)
10/10/2012CN102719368A Cell model for screening inhibitor of mycobacterium tuberculosis and screening method
10/10/2012CN102718977A Heparin sodium-loaded polyurethane micro nanometer particle solution and preparation method and application thereof
10/10/2012CN102718818A Nitrogenous troxerutin derivative, preparation method thereof and application
10/10/2012CN102718817A Method for preparing anthocyanin extract from black bean peel
10/10/2012CN102718816A 4''-O-(trans-beta-aryl allyl amide) formamyl azithromycin derivatives
10/10/2012CN102718809A New diterpene compound in leaves of rubus corchorifolius L.f as well as preparation method and purpose thereof
10/10/2012CN102718795A Dibutyltin coordination compound and preparation method and application thereof
10/10/2012CN102718794A Dihydrazone Schiff base tindiphenyl (IV) coordinate complex and preparation method and application thereof
10/10/2012CN102718793A Phenyltin coordination compound and preparation method and application thereof
10/10/2012CN102718775A Macrocyclic quinazoline derivatives as antiproliferative agents
10/10/2012CN102718772A Preparation and clinic application of hydroxycamptothecin derivative and preparation thereof
10/10/2012CN102718769A Intermediary tetrasubstituted chlorin compound and application thereof in the field of medicines
10/10/2012CN102718759A Heterocyclic CETP inhibitors
10/10/2012CN102718758A Quinolinone derivative and application thereof as anti-schizophrenic drug
10/10/2012CN102718757A 2H-1-benzopyran-2-one compounds with alpha-glucosidase inhibitory activity and medicinal composition of 2H-1-benzopyran-2-one compounds
10/10/2012CN102718751A Pantoprazole salt crystal form and preparation method thereof
10/10/2012CN102718750A Aminopyridine derivatives containing acridine ring and application thereof
10/10/2012CN102718748A Compounds having analgesic and/or immunostimulant activity
10/10/2012CN102718746A Trioxymethylene fumarate crystal form A and pharmaceutical usage thereof
10/10/2012CN102718745A Novel amino pyridine compound, its preparation method, pharmaceutical composition containing compound and application thereof
10/10/2012CN102718744A Compounds and methods for the treatment or prevention of flavivirus infections
10/10/2012CN102718735A 2-ethyl-3-(4-hydroxy) benzoyl benzofuran compounds and compositions and preparation methods of compounds
10/10/2012CN102718730A Methods of synthesis and/or purification of diaminophenothiazinium compounds
10/10/2012CN102718727A Arylurea derivative with dual GK/PPAR agonist activities
10/10/2012CN102718726A (z)-5-benzylidene thiazoline-4-thiazoline derivative as immunomodulator
10/10/2012CN102718721A 4,4-disubstituted-dihydrogen-2(1H)-quinazolone or thioketone compound, synthetic method and application thereof
10/10/2012CN102718710A Morphinan compounds
10/10/2012CN102718708A Novel nitrogen-containing heteroaryl compounds and methods of use thereof
10/10/2012CN102718703A Dimethyl-containing arylurea derivative with dual GK/PPAR agonist activities
10/10/2012CN102718702A Aminopyridine derivatives and application thereof
10/10/2012CN102718696A Preparation method and anti-AIDS purpose of Baculiferin L and analog thereof
10/10/2012CN102718693A Carbazochrome sodium sulfonate compound and composition thereof
10/10/2012CN102718676A Agomelatine sulfate and preparation method thereof
10/10/2012CN102718675A Agomelatine methanesulfonic acid complex and preparation method thereof
10/10/2012CN102718674A Myrcenyl amide as well as synthesis method and applications thereof
10/10/2012CN102718658A Isosteviol derivative as well as preparation method and application thereof
10/10/2012CN102718650A 2-(2- hydroxyl-5-(methoxycarbonyl) phenoxyl) benzoic acid as well as preparation method and application thereof
10/10/2012CN102716498A Drug liposome capable of efficient and highly specific killing of P53 gene mutation type of breast cancer cells
10/10/2012CN102716496A Clathrate compound of scutellarin and alkaline cyclodextrin and preparation method thereof
10/10/2012CN102716494A Nucleic acid medicine loading system for targeted therapy and preparation method of nucleic acid medicine loading system
10/10/2012CN102716493A Copolymer containing amorphous agomelatine, and preparation method, pharmaceutical composition and application thereof
10/10/2012CN102716492A Baicalin hydroxypropyl-beta-cyclodextrin inclusion compound as well as preparation method and application thereof
10/10/2012CN102716491A Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same
10/10/2012CN102716490A Method for preparation of pharmaceutical composition having improved disintegradability
10/10/2012CN102716488A Glycyrrhizic acid aureola dimer mediated targeted medication body as well as preparation method and purpose of glycyrrhizic acid aureola dimer mediated targeted medication body
10/10/2012CN102716487A Permeation enhancer for improving transdermal absorption of Ginsenoside-Rd and application thereof
10/10/2012CN102716486A Slowly-releasing anticancer drug composition and application thereof
10/10/2012CN102716465A Pharmaceutical composite for treating tumor and preparation method of pharmaceutical composite